Suspected Cardiovascular Syncope in the ER

  • Carlos Jerjes-SánchezEmail author
  • Claudia Ortiz-Ledesma
  • Jathniel Panneflek
  • Raul del Toro-Mijares
  • Mauricio Vázquez Guajardo


Syncope is a sudden and transient episode of complete loss of consciousness with spontaneous recovery caused by a brief interruption of cerebral oxygen supply. Syncope is a common complaint in the emergency room, and during the initial evaluation, the cause often remains unclear. Initial approach should focus on risk stratification to determine if the patient requires in-hospital treatment and workup or outpatient treatment. Syncope classification included neutrally mediated, secondary to orthostatic hypotension, and cardiac. Cardiac syncope can be life-threatening. Risk factors for cardiovascular syncope include antihypertensive or antiarrhythmic drugs, family history of sudden cardiac death at a young age (<40 years), and family or personal history of cardiomyopathy or channelopathy. The main pathophysiologic characteristics are hypotension and concomitant cerebral hypoperfusion. There are two cardiac causes: arrhythmias and structural heart disease. In patients with cardiac syncope, the presence of premonitory symptoms like lightheadedness, sweating, palpitations, nausea, or visual blurring is not common. Syncope could be the clinical presentation of low-risk, submassive, or massive PE patients. Thus, assessment of risk factor, a complete clinical history, and information given by eyewitnesses become very valuable. Furthermore, the physical examination should include a complete neurological examination, blood pressure measurements, carotid sinus massage, and careful auscultation with special attention in murmurs, evaluation of pulses, and an electrocardiogram. Depending on the findings, we have high-, intermediate-, or low-risk patients which will help the physician to decide if the patient requires inpatient or outpatient evaluation.


Cardiac syncope Syncope Presyncope 


  1. 1.
    Puppala VK, Dickinson O, Benditt DG. Syncope: classification and risk stratification. J Cardiol. 2014;63:171–7.CrossRefGoogle Scholar
  2. 2.
    Koene RJ, Adkisson WO, Benditt DG. Syncope and the risk of sudden cardiac death: evaluation, management, and prevention. J Arrhythm. 2017;33:533–44.CrossRefGoogle Scholar
  3. 3.
    Shen W-K, Sheldon RS, Benditt DG, Cohen MI, Forman DE, Goldberger ZD, et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Circulation. 2017;136:e25–59.PubMedGoogle Scholar
  4. 4.
    Houser A, Runser LA, Gauer RL. Syncope: evaluation and differential diagnosis. Am Fam Physician. 2017;95:303–312B.PubMedGoogle Scholar
  5. 5.
    Brignole M, Moya A, de Lange FJ, Deharo J-C, Elliott PM, Fanciulli A, et al. 2018 ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39:1883–948.CrossRefGoogle Scholar
  6. 6.
  7. 7.
    Prandoni P, Lensing AWA, Prins MH, Ciammaichella M, Perlati M, Mumoli N, et al. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med. 2016;375:1524–31.CrossRefGoogle Scholar
  8. 8.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Instituto de Cardiología y Medicina Vascular, TecSalud, Escuela de Medicina y Ciencias de la Salud, Tecnológico de MonterreySan Pedro Garza GarcíaMéxico
  2. 2.Centro de Investigación Biomédica del Hospital Zambrano Hellion, TecSalud, Escuela de Medicina, Tecnológico de MonterreySan Pedro Garza GarcíaMéxico
  3. 3.Escuela de Medicina y Ciencias de la Salud, Tecnológico de MonterreyMonterreyMéxico
  4. 4.Universidad de MontemorelosMontemorelosMéxico

Personalised recommendations